PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0376358|prostate cancer |
| Sentences | 10 |
| PubMedID- 21837637 | The burden of depression in prostate cancer. |
| PubMedID- 23398917 | Background: psychosocial strategies are commonly used to alleviate anxiety and depression in patients with prostate cancer. |
| PubMedID- 22855322 | Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. |
| PubMedID- 25443144 | Commentary on "the burden of depression in prostate cancer." jayadevappa r, malkowicz sb, chhatre s, johnson jc, gallo jj, department of medicine, university of pennsylvania school of medicine, philadelphia, pa.: psychooncology 2012;21(12):1338-45. |
| PubMedID- 22459065 | Purpose: current literature describes concern for an increase in depression owing to treatment of prostate cancer. |
| PubMedID- 21612913 | Interpretation: men diagnosed with prostate cancer had increased risk of psychiatric treatment for depression, post-traumatic stress disorder and use of antidepressants regardless of risk group and treatment strategy compared to age-matched controls, whilst more advanced prostate cancer was associated with severe anxiety disorders. |
| PubMedID- 25745628 | The increased incidence and prevalence of depression in men with prostate cancer is cause for concern for an increased risk of suicidal ideation and behavior in such patients. |
| PubMedID- 21882934 | Stage of disease progression moderates the association between social support and depression in prostate cancer survivors. |
| PubMedID- 24625637 | Primary outcome measure: the prevalence of clinical depression and anxiety in patients with prostate cancer as a function of treatment stage. |
| PubMedID- 26002689 | A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance. |
Page: 1